P910018/S042: LIPOSORBER LA-15 System
FDA’s recorded scope: a change in the acceptance criterion for the opening torque test performed during in-process inspection of the SULFLUX KP-05 filter the of LIPOSORBER LA-15 System
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Kaneka Pharma America Corp.. 1 entry is a PMA supplement. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 30, 2026 to Jun 16, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MMY appears in 2 of the 2 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P910018, with 2 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 546 Fifth Ave., 21st Floor, New York, NY, 10036. Recorded on P910018/S042, decision dated Jun 16, 2026.
FDA’s recorded scope: a change in the acceptance criterion for the opening torque test performed during in-process inspection of the SULFLUX KP-05 filter the of LIPOSORBER LA-15 System
FDA’s recorded scope: Approval for a change in the supplier of the lubricant, calcium stearate, added to the polyethylene resin used in the manufacture of the hollow fiber of the device.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIPOSORBER LA-15 SystemP910018/S042 | Kaneka Pharma America Corp. | PMA supplement | Jun 16, 2026 | FDA |
LIPOSORBER LA-15 SystemP910018/S041 | Kaneka Pharma America Corp. | PMA supplement | Mar 30, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.